Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. (Q47549492)
Jump to navigation
Jump to search
scientific article published on 24 January 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. |
scientific article published on 24 January 2018 |
Statements
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults (English)
Barney S Graham
Julie E Ledgerwood
Ingelise Gordon
Richard A Koup
Adrian B McDermott
LaSonji A Holman
Cynthia S Hendel
Richard M Schwartz
Sandeep Narpala
Galina Yamshchikov
Katherine V Houser
Sandra Sitar
Emily E Coates
Kevin Carlton
Michelle Conan-Cibotti
Margarita Gomez Lorenzo
Aryan M Namboodiri
Jamie G Saunders
Robert T Bailer
VRC 606 Study Team
24 January 2018
1 reference